Crossmark

Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects

Published Online: 2020-09-23

Published Print: 2021-02

Authors

Gaudy, Allison https://orcid.org/0000-0001-7677-5927
Atsriku, Christian

Ye, Ying

MacGorman, Kimberly

Liu, Liangang

Xue, Yongjun

Surapaneni, Sekhar

Palmisano, Maria
Funding

Funding for this research was provided by:

Bristol-Myers Squibb
License Information

Text and Data Mining valid from 2020-09-23

Version of Record valid from 2020-09-23
More Information

Article History

Received: 5 May 2020

Accepted: 16 September 2020

First Online: 23 September 2020

Compliance with ethical standards

:

: Allison Gaudy, Ying Ye, Kimberly MacGorman, Christian Atsriku, Liangang Liu, Yongjun Xue, Sekhar Surapaneni and Maria Palmisano are all full-time employees of Bristol Myers Squibb, and own stock in the company.

: Not applicable

Document is current